• OPEN AN ACCOUNT
Indian Indices
Sensex
71,909.70 -570.59
( -0.79%)
Global Indices
Nasdaq
51,190.24 242.68
(0.48%)
Dow Jones
7,742.36 54.91
(0.71%)
Hang Seng
68,256.51 -700.21
(-1.02%)
Nikkei 225
10,455.36 27.09
(0.26%)
Forex
USD-INR
96.17 0.25
(0.26%)
EUR-INR
108.49 -0.30
(-0.28%)
GBP-INR
127.16 -0.03
(-0.02%)
JPY-INR
0.61 0.00
(-0.36%)

EQUITY - MARKET SCREENER

Can Fin Homes Ltd
Industry :  Finance - Housing
BSE Code
ISIN Demat
Book Value()
511196
INE477A01020
449.132266
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
CANFINHOME
8.36
9444.66
EPS(TTM)
Face Value()
Div & Yield %
84.84
2
2.11
 

Shree Ganesh Biotech India reports standalone net loss of Rs 0.15 crore in the March 2026 quarter
May 15,2026
Net Loss of Shree Ganesh Biotech India reported to Rs 0.15 crore in the quarter ended March 2026 as against net loss of Rs 0.95 crore during the previous quarter ended March 2025. Sales declined 29.57% to Rs 2.12 crore in the quarter ended March 2026 as against Rs 3.01 crore during the previous quarter ended March 2025.

For the full year,net profit rose 35.71% to Rs 0.38 crore in the year ended March 2026 as against Rs 0.28 crore during the previous year ended March 2025. Sales declined 78.35% to Rs 4.97 crore in the year ended March 2026 as against Rs 22.96 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales2.123.01 -30 4.9722.96 -78
OPM %-20.28-47.18 --19.11-4.57 -
PBDT-0.15-0.95 84 0.520.39 33
PBT-0.15-0.95 84 0.520.39 33
NP-0.15-0.95 84 0.380.28 36